Statins and perihemorrhagic edema in patients with spontaneous intracerebral hemorrhage
Citation Manager Formats
Make Comment
See Comments

Abstract
Objective To test the hypothesis that in patients with spontaneous intracerebral hemorrhage (ICH), perihemorrhagic edema to hematoma ratio (rPHE) on admission CT scan (aCT) is unaffected by home statin use when time from symptom onset to aCT is controlled for.
Methods In a single-center prospective cohort of 176 consecutive ICH patients, 2 investigators independently determined hematoma and perihemorrhagic edema (PHE) volumes by using semiautomated validated software. rPHE were dichotomized at the median ratio (>0.75 vs ≤0.75). We used binary logistic regression to test for associations with rPHE.
Results In patients using statins as home medication before hospital admission (n = 38) compared to patients without prior statin use (n = 138), median PHE volumes were 15.8 mL (interquartile range [IQR] 6.5–39.4) vs 10.8 mL (IQR 5.1–26.8), p = 0.2. rPHE was 0.71 (IQR 0.56–1.0) vs 0.74 (IQR 0.52–1.0), p = 0.79. In a binary logistic regression model, time of aCT relative to symptom onset (odds ratio [OR] 1.02, confidence interval [CI] 1.01–1.12, p = 0.016) and presence of intraventricular hemorrhage on aCT (OR 0.40, CI 0.20–0.78, p = 0.007) were but prior statin use was not (OR 1.17, CI 0.55–2.52, p = 0.68) associated with rPHE.
Conclusion Use of statins before hospital admission for ICH is not associated with reduced rPHE on admission CT. In future studies, imaging timing relative to ICH onset needs to be controlled for in order to avoid confounding.
Glossary
- aCT=
- admission CT;
- ICH=
- intracerebral hemorrhage;
- IVH=
- intraventricular hemorrhage;
- PHE=
- perihemorrhagic edema;
- rPHE=
- perihemorrhagic edema to hematoma ratio
Footnotes
Go to Neurology.org/N for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the article.
CME Course: NPub.org/cmelist
- Received July 22, 2018.
- Accepted in final form December 14, 2018.
- © 2019 American Academy of Neurology
Disputes & Debates: Rapid online correspondence
NOTE: All authors' disclosures must be entered and current in our database before comments can be posted. Enter and update disclosures at http://submit.neurology.org. Exception: replies to comments concerning an article you originally authored do not require updated disclosures.
- Stay timely. Submit only on articles published within the last 8 weeks.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- 200 words maximum.
- 5 references maximum. Reference 1 must be the article on which you are commenting.
- 5 authors maximum. Exception: replies can include all original authors of the article.
- Submitted comments are subject to editing and editor review prior to posting.